Spectacular efficacy of neoadjuvant chemotherapy in a patient with cervical cancer of IB2 grade according to FIGO 2009 Case report

Article Sidebar

PDF


Published: Jun 30, 2020
DOI: https://doi.org/10.24292/01.OR.220300620.6
Keywords:
cervical cancer, neoadjuvant chemotherapy, positron emission tomography

Main Article Content

Kamila Kaźmierczak
Surgical, Oncological and Endoscopic Gynaecology Department, Greater Poland Cancer Centre, Poznan, Poland
Błażej Nowakowski
1. Surgical, Oncological and Endoscopic Gynaecology Department, Greater Poland Cancer Centre, Poznan, Poland. 2. Department of Oncologic Pathology and Prophylaxis, Poznan University of Medical Sciences, Poznan, Poland
Joanna Kufel-Grabowska
1. Surgical, Oncological and Endoscopic Gynaecology Department, Greater Poland Cancer Centre, Poznan, Poland. 2. Department of Clinical Oncology, Greater Poland Cancer Centre, Poznan, Poland. 3. Chair and Department of Electroradiology, The Faculty of Health Sciences, Poznan University of Medical Sciences, Poznan, Poland
Witold Cholewiński
1. Chair and Department of Electroradiology, The Faculty of Health Sciences, Poznan University of Medical Sciences, Poznan, Poland. 2. Nuclear Medicine Unit, Greater Poland Cancer Centre, Poznan, Poland

Abstract

The presented case report is an example of a spectacular effect of induction systemic treatment in a patient with locally advanced cervical cancer of IB2 grade according to FIGO 2009 (International Federation of Gynecologist and Obstetrician). The effect of induction chemotherapy (three series in paclitaxel/24 h + cisplatin regimen at an interval of three weeks) was the total metabolic response of the primary tumor and nodal lesions found in FDG-PET/CT (18F-fluorodeoxyglucose – positron emission tomography combined with computed tomography) as well as an image of total regression of the tumor in the obtained postoperative histopathological examination.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Article Details

How to Cite
1.
Kaźmierczak K, Nowakowski B, Kufel-Grabowska J, Cholewiński W. Spectacular efficacy of neoadjuvant chemotherapy in a patient with cervical cancer of IB2 grade according to FIGO 2009. OncoReview [Internet]. 2020Jun.30 [cited 2024Nov.22];10(2(38):69-6. Available from: https://journalsmededu.pl/index.php/OncoReview/article/view/1070
Issue
Vol 10 No 2(38) (2020)
Section
GYNECOLOGIC ONCOLOGY
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright: © Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)

References

1. International Agency for Research on Cancer – IARC, Gobocan 2012. Estimated cancer incidence, mortality and prevalence worldwide 2015. http://globocan.iarc.fr.
2. Wojciechowska U, Didkowska J. Zachorowania i zgony na nowotwory złośliwe w Polsce, Krajowy Rejestr Nowotworów, Centrum Onkologii – Instytut im. Marii Skłodowskiej-Curie. http://onkologia.org.pl/raporty (Access: 3.04.2020).
3. Markowska J, Mądry J. Zarys ginekologii onkologicznej. Vol. 1. Termedia, Poznań 2018: 622-30, 797-8, 736-8.
4. Nowakowski A, Kotarski J. Rak szyjki macicy w Polsce i na świecie w świetle danych o zapadalności i umieralności. Przegl Epidemiol. 2011; 65: 75-9.
5. Bidziński M, Dańska-Bidzińska A. Chirurgiczne leczenie raka szyjki macicy. Ginekol Pol. 2007; 78: 723-6.
6. Benedetti-Panici P, Greggi S, Colombo A et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J Clin Oncol. 2002; 20(1): 179-88.
7. Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer Meta-analysis Collaboration. Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomized trials. Eur J Cancer. 2003; 39(17): 2470-86.
8. Rydzewska L, Tierney J, Vale CL et al. Neoadjuvant chemotherapy plus surgery versus for cervical cancer. Cochrane Database Syst Rev. 2012; 12(12): CD007406.
9. Kenter G, Greggi S, Vergote I et al. Results from neoadjuvant chemotherapy followed by surgery compared to chemoradiation for stage Ib2-II b cervical cancer, EORTC 55994. J Clin Oncol. 2019; 37(15 suppl): 5503.
10. Gupta S, Maheshwari A, Parab P et al. Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial. J Clin Oncol. 2018; 36(16): 1548-55.